French multicentre prospective evaluation of radiofrequency ablation in the management of haemorrhoidal disease von Laurain, A., Bouchard, D., Rouillon, J.-M., Petit, P., Liddo, A., Vinson Bonnet, B., Venara, A., Didelot, J.-M., Bonnaud, G., Senéjoux, A., Higuero, T., Delasalle, P., Tarrerias, A.-L., Devulder, F., Castinel, A., Thomas, C., Pillant Le Moult, H., Favreau-Weltzer, C., Abramowitz, L.

Volltext

Retreatment of hepatitis C virus daa failures in real life: easy and difficult to cure patients von Ouzan, D, Penaranda, G, Lefolgoc, G, Antoni, M, Delasalle, P, Fontanges, T, Cerdan, P, Toulemonde, P, Bresson-Hadni, S, Beorchia, S, Boyer, N, Hanslik, B, Joly, H, Liautard, J, Baesjou, S, Bonny, C, Halfon, P, Renou, C, Bourliere, M

Volltext

Efficacy and Safety of IFN Free, Direct-Acting Antiviral-Based Treatment Regimens in Patients with Advanced Liver Disease: Community Treatment of a Real World Population in France von Ouzan, D, Penaranda, G, Delasalle, P, Renou, C, Hanslik, B, Antoni, M, Toulemonde, P, Fontanges, T, Bresson-Hadni, S, Halfon, P, Boyer, N, Liautard, J, Baesjou, S, Bonny, C, Cerdan, P, Bourlière, M

Volltext

AVDLIB 2: News Direct-Acting Antiviral (DDA) in HCV Patients with Advanced Liver Disease. Final Results of a the Second Multicenter Prospective Observational Study in Real Life Pra... von Ouzan, D, Penaranda, G, Delasalle, P, Renou, C, Antoni, M, Toulemonde, P, Halfon, P, Bresson-Hadni, S, Liautard, J, Bourlière, M

Volltext

P0822 : Safety And efficacy of sofosbuvir containing regimens for hepatitis C: Community treatment of a real world population with advanced liver fibrosis von Ouzan, D, Fontanges, T, Pénaranda, G, Delasalle, P, Antoni, M, Bresson-Hadni, S, Cerdan, P, Beorchia, S, Toulemonde, P, Boyer, N, Castelnau, C, Jacques, J.-P, Serge, B, Bonny, C, Boussoukouya, S, Joly, H, Hanslik, B

Volltext

Optimized stepwise combination algorithms of non‐invasive liver fibrosis scores including Hepascore in hepatitis C virus patients von BOURLIERE, M., PENARANDA, G., OUZAN, D., RENOU, C., BOTTA‐FRIDLUND, D., TRAN, A., ROSENTHAL, E., WARTELLE‐BLADOU, C., DELASALLE, P., OULES, V., PORTAL, I., CASTELLANI, P., LECOMTE, L., ROSENTHAL‐ALLIERI, M. A., HALFON, P.

Volltext

Influence of insulin resistance on hepatic fibrosis and steatosis in hepatitis C virus (HCV) mono‐infected compared with HIV–HCV co‐infected patients von HALFON, P., PÉNARANDA, G., CARRAT, F., BEDOSSA, P., BOURLIÈRE, M., OUZAN, D., RENOU, C., TRAN, A., ROSENTHAL, E., WARTELLE, C., DELASALLE, P., CACOUB, P.

Volltext

824 IMPACT OF IL28B GENOTYPE ON HCV TREATMENT DECISION IN A LARGE FRENCH COHORT von Renou, C, Allègre, T, Ouzan, D, Bourlière, M, Delasalle, P, Lafeuillade, A, Cadranel, J.-F, Haddad, N, Asselah, T, Pénaranda, G, Sauser-Chirat, F, Khiri, H, Halfon, P

Volltext

Digestive endoscopies are not a risk factor for transmission of virus C von Boustiere, Ch, Napoleon, B., Delasalle, P., Coulom, P.

Volltext

Predictive Factors for HBsAg Loss in Chronic HBeAg‐Negative Hepatitis B Virus Infection: Insights From a 5‐Year French Cohort von Causse, Xavier, Potier, Pascal, Valéry, Antoine, Labadie, Hélène, Macaigne, Gilles, Cadranel, Jean‐François, Fontanges, Thierry, Mouna, Lina, Roque‐Afonso, Anne‐Marie, Salloum, H., Picon‐Coste, M., Hommel, S, Henrion, J., Arpurt, J. P., Rosa, I., Ollivier, I., Bresson‐Hadni, S, Zanditenas, D., Schnee, M., Heluwaert, F., Cosconea, S, Lambare, B., Garioud, A., Delasalle, P., Renou, C., Hanslik, B., Boyer, N., Castelnau, C.

Volltext

833 LIVER FIBROSIS ASSESSMENT IN CHRONIC HEPATITIS C: EVOLUTION OF CLINICAL PRACTICE IN A LARGE COHORT OF 4546 PATIENTS BETWEEN 2003 AND 2006 von Roudot-Thoraval, F, Ouzan, D, Denis, J, Guyader, D, Doffoel, M, Delasalle, P, Abergel, A, Marcellin, P, Chousterman, M, Hayem, C, Lonjon-Domanec, I, Bourliere, M

Volltext

[731] IMPACT OF MODERATE ALCOHOL CONSUMPTION ON HEPATIC FIBROSIS PROGRESSION IN HCV-INFECTED PATIENTS von Marine Barjoan, E, Gelsi, E, Delasalle, P, Ibragimova, N, Sattonnet, C, Saint-Paul, M.C, Gueyffier, C, Diebolt, E, Hayek, R, Fuzibet, J.G, Ouzan, D

Volltext

THU-259 - Retreatment of hepatitis C virus daa failures in real life: easy and difficult to cure patients von Ouzan, D., Penaranda, G., Lefolgoc, G., Antoni, M., Delasalle, P., Fontanges, T., Cerdan, P., Toulemonde, P., Bresson-Hadni, S., Beorchia, S., Boyer, N., Hanslik, B., Joly, H., Liautard, J., Baesjou, S., Bonny, C., Halfon, P., Renou, C., Bourliere, M.

Volltext

THU-218 - AVDLIB 2: News Direct-Acting Antiviral (DDA) in HCV Patients with Advanced Liver Disease. Final Results of a the Second Multicenter Prospective Observational Study in Rea... von Ouzan, D., Penaranda, G., Delasalle, P., Renou, C., Antoni, M., Toulemonde, P., Halfon, P., Bresson-Hadni, S., Liautard, J., Bourlière, M.

Volltext

Prevention by daily soluble aspirin of colorectal adenoma recurrence: 4-year results of the APACC randomised trial von Benamouzig, Robert, Uzzan, Bernard, Deyra, Jacques, Martin, Antoine, Girard, Bernard, Little, Julian, Chaussade, Stanislas

Volltext

THU-219 - Efficacy and Safety of IFN Free, Direct-Acting Antiviral-Based Treatment Regimens in Patients with Advanced Liver Disease: Community Treatment of a Real World Population... von Ouzan, D., Penaranda, G., Delasalle, P., Renou, C., Hanslik, B., Antoni, M., Toulemonde, P., Fontanges, T., Bresson-Hadni, S., Halfon, P., Boyer, N., Liautard, J., Baesjou, S., Bonny, C., Cerdan, P., Bourlière, M.

Volltext

Cyclooxygenase-2 expression and recurrence of colorectal adenomas: effect of aspirin chemoprevention von Benamouzig, Robert, Uzzan, Bernard, Martin, Antoine, Deyra, Jacques, Little, Julian, Girard, Bernard, Chaussade, Stanislas

Volltext

Validation of hepascore for diagnosis of liver fibrosis in HCV patients and determination of a new algorithm von Bourliere, M, Penaranda, G, Halfon, P, Renou, C, Ouzan, D, Tran, A, Botta-Fridlund, D, Rosenthal, E, Wartelle, C, Delasalle, P, Rosenthal-Allieri, M, Portal, I, Castellani, P, Gerolami, R, Lecomte, L

Volltext

P.363 Validation of hepascore for diagnosis of liver fibrosis in HCV patients and determination of a new algorithm von Bourlière, M., Pénaranda, G., Halfon, P., Renou, C., Ouzan, D., Tran, A., Botta-Fridlund, D., Rosenthal, E., Wartelle, C., Delasalle, P., Rosenthal-Allieri, M., Portal, I., Castellani, P., Gerolami, R., Lecomte, L.

Volltext

High rate of sustained virological response after a 48 weeks course of interferon (IFN) plus ribavirin in chronic hepatitis C relapsers. Results of a randomised trial von Ouzan, D., Longo, F., Renou, C., Baldini, E., Marine-Barjoan, E., Gueyffier, C., Delasalle, P., Cadot, C., Moreau, X., Dreyfus, G., Bianchi, D., Amoros, P., Benzaken, S., Mousnier, A., Halfon, P., Rampal, P., Tran, A.

Volltext